| Oct 2, 2014
| 6:19 PM
Nazareth police said an undercover drug buy Wednesday netted more than 50 bags of heroin, prescription painkillers and synthetic marijuana.
Pedro Alexander Vera, 25, of the 1200 block of Livingston Street, Bethlehem, is charged with manufacturing...
| Oct 3, 2014
| 3:51 PM
This month, negotiations over the Trans-Pacific Partnership resume in Australia. Officials from the United States and 11 other major economies are meeting to settle the final details of the trade pact, with the hope of passing the final deal by year's...
| Oct 4, 2014
| 8:25 AM
Late last year, medical device maker Zimmer Holdings Inc. made two large payments to Dr. Andrew N. Pollak, chair of the University of Maryland Medical System's orthopedics department.
The payments, one for $47,225 and the other for $45,902, were...
| Aug 19, 2014
| 11:23 AM
With the selection of Perry Nisen as its new chief executive officer today, Sanford-Burnham Medical Research Institute is signaling a commitment to its new long-term strategic vision of open collaboration for the development of breakthrough clinical...
| Aug 21, 2014
Glades Drugs, a pharmacy retailer owned and operated by pharmacists, is opening new headquarters in Lake Worth.
The new 8,000-square-foot location at 4560 Lantana Road will feature office space, a lab and pharmacy. Glades Drugs, now based in Boca Raton,...
| Aug 21, 2014
| 12:11 PM
Baxter International Inc. said Thursday a key hemophilia drug under development met its primary goal in a late-stage clinical study.
The drug, known as BAX 855, is essentially a stronger, extended-release version of its flagship hemophilia drug Advate,...
| Aug 11, 2014
| 7:03 PM
A French pharmaceutical company has agreed to pay up to $925 million for the right to market Afrezza, the recently approved inhaled insulin treatment for diabetes developed by MannKind Corp. of Valencia.
Sanofi, based in Paris, said it would pay $150...
| Aug 12, 2014
| 2:18 PM
As U.S. medical experts raised concerns Tuesday about the use of experimental drugs to treat the Ebola virus, makers of the unapproved medication ZMapp said their supply has been "exhausted."
In a statement published online late Monday, Mapp...
| Aug 13, 2014
| 5:00 PM
The Food & Drug Administration on Wednesday approved U.S. marketing of the first in a new class of sleep drugs that targets the brain's wakefulness centers to speed the onset of sleep and reduce nighttime awakening. The new medication, which goes by the...
| Aug 14, 2014
| 1:26 PM
The Securities and Exchange Commission is looking into the way that a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine.
Ackman's hedge fund, Pershing Square Capital Management,...
| Aug 14, 2014
| 4:44 PM
The Securities and Exchange Commission is looking into the way a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine.
Word of the investigation came less than a week after Allergan sued...